Related scientific articles (all)

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

Authors : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Year : 2016
Journal : Eur J Cancer
Volume : 56
Pages : 85-92

Innovative approach to older patients with malignant hemopathies.

Authors : Bron D, Soubeyran P, Fulop T
Year : 2016
Journal : Haematologica
Volume : 101
Pages : 893-5

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Authors : Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G, Lee SC, Mehta AO, Kim SB, Bachelot T, Goswami C, Deo S, Bose R, Wong A, Xu F, Yao B, Bryce R, Carey LA
Year : 2016
Journal : JAMA Oncol
Volume : 2(12)
Pages : 1557-64

Moderne indications for endoscopic endonasal surgery

Authors : Lipski SM, Digonnet A, Dolhen P
Year : 2016
Journal : EMJ Oncology
Volume : -
Pages : -

(1, 3)-ß-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.

Authors : Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F
Year : 2016
Journal : Oncotarget
Volume : 7(16)
Pages : 21484-95

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.

Authors : Aspeslagh S, Awada A, S Matos-Pita A, Aftimos P, Bahleda R, Varga A, Soria JC
Year : 2016
Journal : Anticancer Drugs
Volume : 27
Pages : 1021-7

Phase 2 Study of Trabectedin in Patients With Hormone Receptor-Positive, HER-2-Negative, Advanced Breast Carcinoma According to Expression of Xeroderma Pigmentosum G Gene.

Authors : Awada A, Cortés J, Martín M, Aftimos P, Oliveira M, López-Tarruella S, Espie M, Lardelli P, Extremera S, Fernández-García EM, Delaloge S
Year : 2016
Journal : Clin Breast Cancer
Volume : 16(5)
Pages : 364-71

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation.

Authors : Cairns L, Aspeslagh S, Anichini A, Kyte JA, Blank C, Ascierto P, Rekers N, Straten PT, Awada A
Year : 2016
Journal : Ecancermedicalscience
Volume : 10
Pages : 691

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Authors : Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, Von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J, + collaborators (among others :, Nogaret JM
Year : 2016
Journal : Lancet
Volume : 387
Pages : 866-73

Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.

Authors : Li R, Swaelens C, Vandermijnsbrugge F, Cantinieaux B
Year : 2016
Journal : Eur. J. Haematol.
Volume : 96(6)
Pages : 578-85

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.

Authors : Harbeck N, Huang CS, Hurvitz S, Yeh DC, Shao Z, Im SA, Jung KH, Shen K, Ro J, Jassem J, Zhang Q, Im YH, Wojtukiewicz M, Sun Q, Chen SC, Goeldner RG, Uttenreuther-Fischer M, Xu B, Piccart-Gebhart M
Year : 2016
Journal : Lancet Oncol
Volume : 17(3)
Pages : 357-66

MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.

Authors : Denis H, Van Grembergen O, Delatte B, Dedeurwaerder S, Putmans P, Calonne E, Rothé F, Sotiriou C, Fuks F, Deplus R
Year : 2016
Journal : Mol Biosyst
Volume : 12(2)
Pages : 404-13

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Authors : Cardoso F, Vant Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, Delorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart-Gebhart M
Year : 2016
Journal : N Engl J Med
Volume : 375(8)
Pages : 717-29

Corrigendum to Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]."

Authors : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Year : 2016
Journal : J Geriatr Oncol
Volume : 7
Pages : 142-143

Screening leading to diagnosis of C cell disease. (in Tyroid cancer : a clinical casebook.) (D. Cooper & C. Durante Eds. Springer)

Authors : Costante G
Year : 2016
Journal : Book
Volume : -
Pages : 377-85

Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy.

Authors : Drisis S, Metens T, Ignatiadis M, Stathopoulos K, Chao SL, Lemort M
Year : 2016
Journal : Eur Radiol
Volume : 26(5)
Pages : 1474-84

Genomic Characterization of Primary Invasive Lobular Breast Cancer.

Authors : Desmedt C, Zoppoli G, Gundem G, Pruneri G, Larsimont D, Fornili M, Fumagalli D, Brown D, Rothé F, Vincent D, Kheddoumi N, Rouas G, Majjaj S, Brohée S, Van Loo P, Maisonneuve P, Salgado R, Van Brussel T, Lambrechts D, Bose R, Metzger O, Galant C, Bertucci F, Piccart-Gebhart M, Viale G, Biganzoli E, Campbell PJ, Sotiriou C
Year : 2016
Journal : J Clin Oncol
Volume : 34(16)
Pages : 1872-81

Bladder and vaginal transitional cell carcinoma: A case report.

Authors : Aoun F, Kourie HR, El Rassy E, Van Velthoven R
Year : 2016
Journal : Oncol Lett
Volume : 12
Pages : 2181-2183

Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.

Authors : Durkin K, Rosewick N, Artesi M, Hahaut V, Griebel P, Arsic N, Burny A, Georges M, Van den Broeke A
Year : 2016
Journal : Retrovirology
Volume : 13
Pages : 33

I-SPY 2: optimising cancer drug development in the 21st century.

Authors : Bartsch R, de Azambuja E
Year : 2016
Journal : ESMO Open
Volume : 1
Pages : e000113